References - Homocysteine in Protein Structure/Function and Human Disease - page 145

281. Kajiya A, Kaji H, Isobe T, Takeda A. Processing of amyloid beta-peptides by neutral cysteine
protease bleomycin hydrolase. Protein Pept Lett. 2006;13(2):119-23.
282. Papassotiropoulos A, Bagli M, Jessen F, Frahnert C, Rao ML, Maier W, et al. Confirmation of
the association between bleomycin hydrolase genotype and Alzheimer's disease. Mol Psy-
chiatry. 2000;5(2):213-5.
283. Lefterov IM, Koldamova RP, Lefterova MI, Schwartz DR, Lazo JS. Cysteine 73 in
bleomycin hydrolase is critical for amyloid precursor protein processing. Biochem Biophys
Res Commun. 2001;283(4):994-9.
284. Kajiya A, Kaji H, Isobe T, Takeda A. Processing of amyloid beta-peptides by neutral cysteine
protease bleomycin hydrolase. Protein Pept Lett. 2006;13(2):119-23.
285. Ratovitski T, Chighladze E, Waldron E, Hirschhorn RR, Ross CA. Cysteine proteases
bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant
huntingtin. J Biol Chem. 2011;286(14):12578-89.
286. Kamata Y, Maejima H, Watarai A, Saito N, Katsuoka K, Takeda A, et al. Expression of
bleomycin hydrolase in keratinization disorders. Arch Dermatol Res. 2012;304(1):31-8.
287. Kamata Y, Taniguchi A, Yamamoto M, Nomura J, Ishihara K, Takahara H, et al. Neutral
cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin
into amino acids. J Biol Chem. 2009;284(19):12829-36.
288. O'Farrell PA, Gonzalez F, Zheng W, Johnston SA, Joshua-Tor L. Crystal structure of human
bleomycin hydrolase, a self-compartmentalizing cysteine protease. Structure. 1999;7
(6):619-27.
289. van Guldener C, Stehouwer CD. Homocysteine metabolism in renal disease. Clin Chem Lab
Med. 2003;41(11):1412-7.
290. Carson NA, Dent CE, Field CM, Gaull GE. Homocystinuria: clinical and pathological review
of ten cases. J Pediatr. 1965;66:565-83.
291. Freeman JM, Finkelstein JD, Mudd SH. Folate-responsive homocystinuria and “schizophre-
nia”. A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase
activity. N Engl J Med. 1975;292(10):491-6.
292. Rassin DK, Longhi RC, Gaull GE. Free amino acids in liver of patients with homocystinuria
due to cystathionine synthase deficiency: effects of vitamin B6. J Pediatr. 1977;91(4):574-7.
293. Kanwar YS, Manaligod JR, Wong PW. Morphologic studies in a patient with homocystinuria
due to 5, 10-methylenetetrahydrofolate reductase deficiency. Pediatr Res. 1976;10
(6):598-609.
294. Stein WH, Moore S. The free amino acids of human blood plasma. J Biol Chem. 1954;211
(2):915-26.
295. Glushchenko AV, Jacobsen DW. Molecular targeting of proteins by L-homocysteine: mech-
anistic implications for vascular disease. Antioxid Redox Signal. 2007;9(11):1883-98.
296. Noel JK, Hunter MJ. Bovine mercaptalbumin and non-mercaptalbumin monomers. Intercon-
versions and structural differences. J Biol Chem. 1972;247(22):7391-406.
297. Jakubowski H. New method for the determination of protein N-linked homocysteine. Anal
Biochem. 2008;380(2):257-61.
298. Perla-Kajan J, Marczak L, Kajan L, Skowronek P, Twardowski T, Jakubowski H. Modifica-
tion by homocysteine thiolactone affects redox status of cytochrome c. Biochemistry.
2007;46(21):6225-31.
299. Akchiche N, Bossenmeyer-Pourie C, Kerek R, Martin N, Pourie G, Koziel V, et al.
Homocysteinylation of neuronal proteins contributes to folate deficiency-associated
alterations of differentiation, vesicular transport, and plasticity in hippocampal neuronal
cells. FASEB J. 2012;26(10):3980-92.
300. Uji Y, Motomiya Y, Hanyu N, Ukaji F, Okabe H. Protein-bound homocystamide measured in
human plasma by HPLC. Clin Chem. 2002;48(6 Pt 1):941-4.
301. Perna AF, Satta E, Acanfora F, Lombardi C, Ingrosso D, De Santo NG. Increased plasma
protein homocysteinylation in hemodialysis patients. Kidney Int. 2006;69(5):869-76.